Status:
COMPLETED
Evaluation of Barriers to Cancer Care Delivery and Outcomes for Women of Color With Metastatic Breast Cancer
Lead Sponsor:
Thomas Jefferson University
Collaborating Sponsors:
Pfizer
Conditions:
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This study evaluates disparities and barriers in cancer care delivery and outcomes in women of color by identifying socioeconomic variables that may be related to the inequity. Social determinants of ...
Detailed Description
This is a single arm study that seeks to identify disparities in delivery of care and treatment outcomes for metastatic breast cancer patients of color and to identify socioeconomic variables that may...
Eligibility Criteria
Inclusion
- Female
- Aged 18 and older
- English-speaking
- Diagnosed with metastatic breast cancer within 24 months of study enrollment
- Receiving treatment at the SKCC in Center City, New Jersey, or Methodist Hospital
- Provide signed and dated informed consent form
- Willing to comply with all study procedures and be available for the duration of the study
Exclusion
- Male breast cancer patients
- Women with breast cancer that is not metastatic
- Women who discontinue treatment for their metastatic disease at SKCC
Key Trial Info
Start Date :
March 9 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06206239
Start Date
March 9 2022
End Date
March 31 2024
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107